Haemostatic markers of procoagulant imbalance in Behçet's disease.
Haznedaroğlu
I C
IC
Ozcebe
O
O
Celik
I
I
Dündar
S V
SV
Kirazhi
S
S
D000328:Adult; D000933:Antifibrinolytic Agents / Q000378:metabolism*; D000990:Antithrombin III / Q000032:analysis*; D001528:Behcet Syndrome / Q000097:blood*; D005260:Female; D005341:Fibrinolysin / Q000378:metabolism*; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000032:analysis*; D010447:Peptide Hydrolases / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D013927:Thrombosis / Q000097:blood; D000979:alpha-2-Antiplasmin
D000933:Antifibrinolytic Agents; D010446:Peptide Fragments; D000979:alpha-2-Antiplasmin; C046193:antithrombin III-protease complex; C037742:plasmin-plasmin inhibitor complex; C045879:prothrombin fragment 1.2; D000990:Antithrombin III; D011516:Prothrombin; D010447:Peptide Hydrolases; D005341:Fibrinolysin